|
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
1 |
[GO] |
2025―Jan―29 |
Modulations of circadian blood pressure rhythm in the COVID-19 risk model in individuals with arterial hypertension under Arctic watch conditions |
N. P. Shurkevich, A. S. Vetoshkin, M. A. Kareva |
2 |
[GO] |
2024―Aug―02 |
The effectiveness of a multi-target therapy polypill in patients with hypertension and dyslipidemia after novel coronavirus infection |
V. E. Oleinikov, I. V. Avdeeva, K. I. Pavlenko, I. A. Babkina, Yu. A. Tomashevskaya |
3 |
[GO] |
2024―Jul―03 |
Prospective comparative analysis of the ambulatory blood pressure monitoring changes in patients with hypertension after COVID-19 in the conditions of the Arctic watch |
A. S. Vetoshkin, N. P. Shurkevich, L. I. Gapon, M. A. Kareva |
4 |
[GO] |
2023―Dez―25 |
Hypertension and COVID-19 - current state and prospects |
I. V. Dolgalev, Iu. G. Samoilova, K. Yu. Maksimova, A. Yu. Ivanova, M. V. Matveeva, E. A. Starovoytova, et al. (+2) N. A. Kirillova, S. V. Fedosenko |
5 |
[GO] |
2023―Dez―25 |
Hypertension and COVID-19 in the conditions of the Arctic watch (according to the data of the medical unit in Yamburg) |
N. P. Shurkevich, A. S. Vetoshkin, L. I. Gapon, M. A. Kareva |
6 |
[GO] |
2023―Dez―25 |
Influence of a new coronavirus infection on the arterial stiffness in patients with hypertension |
I. V. Avdeeva, K. I. Pavlenko, L. I. Salyamova, M. V. Lukyanova, V. E. Oleinikov |
7 |
[GO] |
2023―Mai―16 |
Clinical and laboratory characteristics of COVID-19 in hospitalized hypertensive patients |
A. A. Abilbayeva, A. S. Tarabayeva, G. M. Idrisova, R. A. Yegemberdiyeva, A. K. Abdrakhmanova, A. M. Sadykova, A. K. Duisenova |
8 |
[GO] |
2022―Nov―10 |
Management of patients with hypertension, coronary heart disease and chronic heart failure during the COVID-19 pandemic in the primary care setting |
A. O. Konradi, O. M. Drapkina, S. V. Nedogoda, G. P. Arutyunov, Yu. A. Karpov, Zh. D. Kobalava, et al. (+3) Ya. A. Orlova, D. A. Sychev, S. K. Zyryanov |
9 |
[GO] |
2022―Mrz―18 |
Blood pressure control, target organ protection and metabolic disorders control using a fixed combination of azilsartan medoxomil + chlorthalidone in hypertensive patients survived after severe and extremely severe COVID-19 |
S. V. Nedogoda, A. A. Ledyaeva, A. S. Salasyuk, E. V. Chumachek, V. V. Tsoma, V. O. Lutova, et al. (+5) E. A. Popova, D. S. Vlasov, O. I. Bychkova, V. A. Labaznikova, K. S. Evdokimov |
10 |
[GO] |
2022―Mrz―18 |
Etiopathogenetic factors and the course of hemorrhagic stroke associated with COVID-19 |
L. B. Novikova, R. F. Latypova, A. I. Novikov |
11 |
[GO] |
2022―Mrz―18 |
The effect of renin-angiotensin-aldosterone system blockers on the course of COVID-19 in patients with arterial hypertension |
T. S. Sveklina, M. S. Tyuryupov, V. A. Medvedeva, S. B. Shustov, A. N. Kuchmin, V. A. Kozlov |
12 |
[GO] |
2022―Mrz―18 |
The role of membrane and circulating forms of ACE 2 in pathological processes in COVID-19 infection |
Y. V. Cheburkin, D. L. Sonin, A. S. Polozov, P. A. Mateikovich, E. V. Savochkina, M. M. Galagudza |
13 |
[GO] |
2021―Okt―20 |
Hypokalemia and the renin-angiotensinaldosterone system activity in COVID-19 patients |
A. I. Tsiberkin, K. А. Golovatyuk, E. S. Bykova, A. T. Andreeva, M. A. Vashukova, U. A. Tsoy, T. L. Karonova |
14 |
[GO] |
2021―Apr―08 |
Clinical and psychological aspects of insomnia associated with COVID-19 pandemic |
A. N. Alekhin, N. O. Leonenko, V. V. Kemstach |
15 |
[GO] |
2020―Dez―14 |
Statins: unexpected help in COVID-19 |
D. F. Gareeva, T. I. Musin, V. N. Pavlov, P. A. Davtyan, V. Sh. Ishmetov, M. R. Plotnikova, et al. (+5) A. V. Pavlov, Benzhi Cai, P. Stricker, K. Carvalho, N. Sh. Zagidullin |
16 |
[GO] |
2020―Aug―28 |
Obesity and COVID-19 |
E. N. Kravchuk, A. E. Neimark, A. Yu. Babenko, E. N. Grineva |
17 |
[GO] |
2020―Aug―28 |
Hypokalemia in hospitalized patients with pneumonia associated with COVID-19 |
A. I. Tsiberkin, N. A. Klyaus, Yu. V. Sazonova, A. P. Semenov |
18 |
[GO] |
2020―Aug―28 |
The management of patients with neurological diseases during the COVID-19 pandemic |
M. P. Topuzova, T. M. Alekseeva, A. D. Chaykovskaya, I. K. Ternovyh, P. Sh. Isabekova |
19 |
[GO] |
2020―Aug―28 |
COVID-19: what are the risks for patients with sleep disorders? |
L. S. Korostovtseva, M. V. Bochkarev, A. A. Shumeyko, N. G. Kucherenko, A. N. Bebekh, А. I. Gorelov, et al. (+2) Yu. V. Sviryaev, A. O. Konradi |
20 |
[GO] |
2020―Jun―26 |
Role of renin-angiotensin-aldosterone system in the interaction with coronavirus SARS-CoV-2 and in the development of strategies for prevention and treatment of new coronavirus infection (COVID-19) |
A. Ya. Fisun, D. V. Cherkashin, V. V. Tyrenko, C. V. Zhdanov, C. V. Kozlov |
21 |
[GO] |
2020―Jun―26 |
Vitamin D deficiency as a factor for immunity stimulation and lower risk of acute respiratory infections and COVID-19 |
T. L. Karonova, M. A. Vashukova, D. A. Gusev, K. A. Golovatuk, E. N. Grineva |
22 |
[GO] |
2020―Jun―26 |
Heart ultrasound in COVID-19 |
O. N. Dzhioeva, O. M. Drapkina |
23 |
[GO] |
2020―Jun―26 |
Neurological and mental disorders associated with COVID-19 |
L. B. Novikova, A. P. Akopian, K. M. Sharapova, R. F. Latypova |
24 |
[GO] |
2020―Jun―26 |
Cardiac damage in patients with COVID-19 coronavirus infection |
N. G. Poteshkina, M. A. Lysenko, E. A. Kovalevskaya, D. S. Fomina, I. V. Samsonova, V. V. Parshin, et al. (+2) O. V. Manchenko, O. Y. Evsyukov |
25 |
[GO] |
2020―Jun―26 |
Diabetes mellitus and COVID-19. How are they connected? Current strategy of fight |
A. Yu. Babenko, M. Yu. Laevskaya |
26 |
[GO] |
2020―Jun―26 |
Practical recommendations for physical rehabilitation in patients with severe COVID-19 in intensive care units |
E. A. Demchenko, V. V. Krasnikova, S. N. Yanishevskiy |
27 |
[GO] |
2020―Jun―26 |
COVID-19 mathematical forecasting in the Russian Federation |
I. A. Lakman, A. A. Agapitov, L. F. Sadikova, O. V. Chernenko, S. V. Novikov, D. V. Popov, et al. (+5) V. N. Pavlov, D. F. Gareeva, B. T. Idrisov, A. R. Bilyalov, N. Sh. Zagidullin |
28 |
[GO] |
2020―Jun―26 |
Healthcare for stroke patients in COVID-19 pandemic |
S. N. Yanishevskiy |
29 |
[GO] |
2020―Jun―26 |
Recommendations on the diagnosis and management of pulmonary hypertension during COVID-19 pandemic |
M. A. Simakova, N. S. Goncharova, D. V. Karpova, E. V. Karelkina, O. M. Moiseeva |
30 |
[GO] |
2020―Jun―26 |
Renin-angiotensin-aldosterone system in new coronavirus infection 2019 |
N. Sh. Zagidullin, D. F. Gareeva, V. Sh. Ishmetov, A. V. Pavlov, M. R. Plotnikova, A. E. Pushkareva, V. N. Pavlov |
31 |
[GO] |
2020―Jun―26 |
Pandemic: the view of a clinical psychologist |
A. N. Alekhin, E. A. Dubinina |
32 |
[GO] |
2020―Mai―07 |
COVID-19: what are the risks in hypertensive patients? |
L. S. Korostovtseva, O. P. Rotar, A. O. Konradi |